<em>APOE</em> Mutation Linked to Protection From Alzheimer&rsquo;s: Case Study
APOE Mutation Linked to Protection From Alzheimer’s: Case Study
A woman whose DNA suggested she’d develop early-onset dementia staved off cognitive decline for decades.
APOE Mutation Linked to Protection From Alzheimer’s: Case Study
APOE Mutation Linked to Protection From Alzheimer’s: Case Study

A woman whose DNA suggested she’d develop early-onset dementia staved off cognitive decline for decades.

A woman whose DNA suggested she’d develop early-onset dementia staved off cognitive decline for decades.

cognitive decline
Genetic Risk for Alzheimer&rsquo;s Disease Linked to Highly Active Brains
Genetic Risk for Alzheimer’s Disease Linked to Highly Active Brains
Diana Kwon | Oct 1, 2019
A growing body of evidence supports the theory that neural hyperactivity and hyperconnectivity precede the pathological changes that lead to neurodegeneration.
Computers Extract Disease Clues from Speech
Computers Extract Disease Clues from Speech
Jef Akst | May 1, 2019
AI models can pick up subtle alterations in linguistic and vocal attributes of spoken language that may be indicative of failing health.
Young Blood Unproven as Anti-Aging Treatment: US FDA
Young Blood Unproven as Anti-Aging Treatment: US FDA
Carolyn Wilke | Feb 20, 2019
The agency warns that plasma treatments costing thousands of dollars, which supposedly treat the infirmities of old age, have not been proven “safe or effective.”
Air Pollution Linked to Decline in Cognitive Performance
Air Pollution Linked to Decline in Cognitive Performance
Shawna Williams | Aug 28, 2018
A study compares verbal and math test scores to air quality measurements in China and finds a correlation.
Researchers Develop Potential Blood Test for Alzheimer’s Disease
Researchers Develop Potential Blood Test for Alzheimer’s Disease
Catherine Offord | Feb 2, 2018
The test uses levels of plasma amyloid-β to estimate the buildup of protein plaques in the brain.
Equivocal Findings of Alzheimer’s Trial Using Young Blood
Equivocal Findings of Alzheimer’s Trial Using Young Blood
Catherine Offord | Nov 6, 2017
A team of Stanford University researchers say that administering young people’s blood plasma to Alzheimer’s patients could improve cognitive function, but the results have been criticized.
How Microbes May Influence Our Behavior
How Microbes May Influence Our Behavior
Amy Lewis | Sep 1, 2017
Researchers are piecing together the links between the gut microbiome and mental health.
Evidence Lacking for Brain-Training Products
Evidence Lacking for Brain-Training Products
Ben Andrew Henry | Oct 4, 2016
A literature review finds little evidence that commercial brain-training games can improve everyday cognitive performance, citing methodological shortcomings.
Immunotherapy for Alzheimer’s Disease Shows Promise
Immunotherapy for Alzheimer’s Disease Shows Promise
Alison F. Takemura | Aug 31, 2016
Biogen’s aducanumab reduces amyloid-β plaques in a dose-dependent manner, according to interim results of a Phase 1b clinical trial.